Holen Sie sich die Stockscreener-App
121.87
0.84%
-1.03
Handel nachbörslich:
121.79
-0.08
-0.07%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ILMN?
Forum
Prognose
Aktiensplit
Illumina Inc Aktie (ILMN) Neueste Nachrichten
Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics - PR Newswire
Illumina Genome Push Raises Questions On Growth, Adoption And Valuation - simplywall.st
Illumina launches TruPath Genome, setting a new standard in genomic insight - Investing News Network
Illumina Launches TruPath Genome Workflow Solution - marketscreener.com
Illumina's TruPath Genome offers rapid whole genome testing for rare disease - Stock Titan
NovaSeq X Series innovation roadmap - Illumina
Next Generation Sequencing Market Competitive Landscape - GlobeNewswire
Illumina unveils NovaSeq X upgrades with 40% output increase - Investing.com Australia
Illumina, Inc. (ILMN) Stock Analysis: Exploring a 15.62% Potential Upside in the Genomics Sector - DirectorsTalk Interviews
Faster DNA decoding: Illumina’s NovaSeq X gets 40% more data, higher accuracy - Stock Titan
Illumina Beat Q4 Earnings and Closed a $350M Acquisition. Here’s What Investors Need to Know - TIKR.com
Why Illumina Inc. stock is a must watch in 20252025 Support & Resistance & Free Verified High Yield Trade Plans - mfd.ru
Illumina SVP Leckman sells $275k in stock By Investing.com - Investing.com South Africa
Illumina SVP Leckman sells $275k in stock - Investing.com Australia
Is It Time To Reassess Illumina (ILMN) After Recent Share Price Volatility - Yahoo Finance
We Think That There Are Some Issues For Illumina (NASDAQ:ILMN) Beyond Its Promising Earnings - 富途牛牛
Insider Sell: Patricia Leckman Sells Shares of Illumina Inc (ILM - GuruFocus
Illumina Stock is Down 80% From Its All-Time Highs: Can It Recover in 2026? - TIKR.com
DNA Sequencing Market Is Booming So Rapidly by 2033 | Thermo Fisher Scientific, Inc., Illumina - openPR.com
Illumina Single Cell RNA Seq helps advance avian conservation - Illumina
Buyout Rumor: What is the Moat Score of Illumina IncMarket Performance Summary & Weekly Top Stock Performers List - baoquankhu1.vn
Illumina To Webcast Upcoming Investor Conference - marketscreener.com
Illumina, Inc. (ILMN) Stock Analysis: Evaluating a 16% Upside Potential Amidst Strong Growth Metrics - DirectorsTalk Interviews
Decoding early synaptic failure in Alzheimer’s disease through multiomic analysis - Illumina
Illumina’s AI-Driven Data Vision Is Expanding — Will Multiomics Integration Unlock a Transformational Edge? - Smartkarma
The future of global food security may depend on quality agrigenomics software - Illumina
Illumina Conservation Deal Highlights New Genomics Demand And Valuation Debate - Sahm
How Illumina Inc. stock performs during Fed tightening cyclesDip Buying & Stepwise Entry and Exit Trade Signals - mfd.ru
Illumina (NASDAQ:ILMN) Upgraded by Wall Street Zen to Strong-Buy Rating - MarketBeat
From sample to insight: Streamlining analysis with the Illumina 5-base solution - Illumina
Illumina completes acquisition of SomaLogic from Standard BioTools - BizWest
Decoding Our DNA: The Human Impact Behind SNP Genotyping’s USD 19.48 Billion Growth by 2034 - GlobeNewswire Inc.
Illumina, Inc. $ILMN Stock Holdings Lowered by Rhumbline Advisers - MarketBeat
Krilogy Financial LLC Takes $1.34 Million Position in Illumina, Inc. $ILMN - MarketBeat
Illumina Crash 10% on Earnings: Why the Stock Could Rebound to $185 in 2026 - TIKR.com
Decoding Illumina Inc (ILMN): A Strategic SWOT Insight - GuruFocus
How Illumina Inc. stock trades before earningsGap Down & Weekly High Return Stock Opportunities - mfd.ru
Illumina (ILMN) is a Top-Ranked Growth Stock: Should You Buy? - Nasdaq
Illumina Q4 Earnings & Revenues Top Estimates, Stock Dips - Nasdaq
Illumina's (NASDAQ:ILMN) Profits Appear To Have Quality Issues - Yahoo Finance
5 Insightful Analyst Questions From Illumina's Q4 Earnings Call - Finviz
5 Insightful Analyst Questions From Illumina’s Q4 Earnings Call - Yahoo Finance
Insider Buying: Scott Gottlieb Acquires Shares of Illumina Inc (ILMN) - GuruFocus
Scott Gottlieb Buys 200 Shares of Illumina (NASDAQ:ILMN) Stock - MarketBeat
Ngs Oncology Market Is Going to Boom | Illumina • Roche • Thermo Fisher Scientific - openPR.com
Simplifying library prep: All in a day’s work for Louise Fraser - Illumina
Can Illumina Inc. (ILU) stock expand revenue streams2025 Bull vs Bear & Comprehensive Market Scan Insights - mfd.ru
Illumina Looks To Clinical Consumables And China Restart To Offset Intensifying NGS Price Pressure - Citeline News & Insights
Spatial Genomics and Transcriptomics Market size to cross - openPR.com
Illumina, Inc. $ILMN Shares Sold by GUARDCAP ASSET MANAGEMENT Ltd - MarketBeat
Introduction to the MiSeq™ i100 Series Tech Support Webinar - Illumina
Multiomics Market Forecast Through 2033: Size, Share, Trends, - openPR.com
My path to Illumina - Illumina
Unlocking Illumina (ILMN) International Revenues: Trends, Surprises, and Prospects - Yahoo Finance
This Week in Chancery Court: Trump Media SPAC Appeal, Illumina - Bloomberg Law News
Illumina, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - 富途牛牛
Diamond Hill Capital Management Inc. Has $32.57 Million Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
0.83%
0.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):